| Net income | |
| Depreciation | 10.27M |
| Amortization | 6.4M |
| Net loss attributable to noncontrolling interest | |
| Provision for loan and lease losses | 13.94M |
| Provision for losses on foreclosed and repossessed assets | |
| Writedown of other assets | |
| Net amortization (accretion) of investment securities AFS | 3.45M |
| Net gains on investment securities AFS | |
| Originations and purchases of mortgage loans for sale | -204.09M |
| Proceeds from sales of mortgage loans for sale | 191.92M |
| Net accretion of covered loans | |
| Accretion of FDIC loss share receivable, net of amortization of FDIC clawback payable | |
| (Gains) losses on dispositions of premises and equipment, foreclosed and repossessed assets and other assets | |
| Gains on FDIC-assisted acquisitions | |
| Deferred income tax expense | 4.1M |
| Increase in cash surrender value of bank owned life insurance ("BOLI") | |
| Current tax benefit on exercise of stock options | |
| Compensation expense under stock-based compensation plans | 7.95M |
| Accrued interest receivable | 4.83M |
| Other assets, net | -5.43M |
| Accrued interest payable and other liabilities | |
| Net cash provided by operating activities | |
| Proceeds from sales of investment securities AFS | 0 |
| Proceeds from maturities/calls/paydowns of investment securities AFS | 145.39M |
| Purchases of investment securities AFS | -382.58M |
| Net paydowns of portfolio loans and leases | |
| Net cash flow from covered assets | |
| Purchases of premises and equipment | -34.46M |
| Proceeds from disposition of premises and equipment, foreclosed and repossessed assets and other assets | 22.68M |
| Cash paid for interest in unconsolidated investments and noncontrolling interest | |
| Purchase of BOLI | -145M |
| Net cash proceeds received in FDIC-assisted acquisitions | 2.12M |
| Net cash provided by investing activities | |
| Net decrease in deposits | 2.59B |
| Net repayments of other borrowings | |
| Net (decrease) increase in repurchase agreements with customers | 4.84M |
| Proceeds from exercise of stock options | 1.26M |
| Current tax benefit on exercise of stock options | |
| Cash dividends paid on common stock | -42.19M |
| Net cash used by financing activities | |
| Net increase (decrease) in cash and cash equivalents | 878.53M |
| Cash and cash equivalents - beginning of period | 90.99M |
| Cash and cash equivalents - end of period | 969.52M |